chemotherapy for breast cancer what to expect

Exploring Factors Influencing Resilience in Women who Completed Chemotherapy for Breast Cancer in Accra Metropolis

Exploring Factors Influencing Resilience in Women who Completed Chemotherapy for Breast Cancer in Accra Metropolis

... how women with breast cancer adapt to breast cancer diagnosis and chemotherapy treatments 1.5 Research Questions 1 What are the breast cancer survivors ‘experiences following chemotherapy treatment? ... resilience in women who completed chemotherapy for breast cancer in Accra Metropolis? 4 How do women with breast cancer adapt to breast cancer diagnosis and chemotherapy treatments? 1.5 Significance ... with Breast Cancer who had Received Chemotherapy .120 5.3 The Support Systems that Influenced Resilience among Breast Cancer Survivors .125 5.4 Adaptation to Breast Cancer Diagnosis and Chemotherapy

Ngày tải lên: 31/07/2019, 00:38

227 54 0
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: A retrospective study

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: A retrospective study

... on Cancer; CT: Chemotherapy; ER: Estrogen receptor; HER2: Human epidermal receptor 2; HR: Hormone receptor; IHC: Immunohistochemistry; LABC: Locally advanced breast cancer; NAC: Neoadjuvant chemotherapy; ... not routinely performed All breast cancer was diag-nosed by biopsy Immunohistochemistry (IHC) was used to determine estrogen receptor (ER), progesterone recep-tor (PR) status For this analysis ... advanced breast cancer, especially for patients with large tumor size, lymph node metasta-sis, HER2 overexpression, triple negative breast cancer (TNBC) subtype, or inflammatory breast cancer The

Ngày tải lên: 03/07/2020, 01:26

11 39 0
Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden

Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden

... lymphocytes, RCB residual cancer burden, TNBC triple-negative breast cancer, HER2BC human epidermal growth factor receptor 2-enriched breast cancer, HRBC hormone receptor-positive breast cancer, pCR pathological ... method for the analysis of survival after NAC found that, for the triple-negative breast cancer (TNBC) and hormone receptor-positive breast cancer (HRBC) subtypes, RCB evaluation was useful for ... scintigraphy Breast cancer was classified into subtypes according to the immunohistochemical expressions of estrogen receptor (ER), progesterone receptor (PgR), HER2, and Ki67 Based on their immunohistochemical

Ngày tải lên: 23/07/2020, 23:58

10 42 0
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

... a predictor of pCR and was associated with higher DFS and DSS in locally advanced breast cancer patients subjected to NAC Keywords: Breast cancer, CAIX, Glycolytic metabolism, Immunohistochemistry, ... committee Clinical and anatomopathological data from 328 female patients admitted consecutively to Barretos Cancer Hospital from 2005 to 2011, with locally ad-vanced breast cancer, clinical stage ... Medicine of Ribeirão Preto, University of São Paulo, Ribreirão Preto, São Paulo, Brazil 8 Department of Mastology and Breast Reconstruction, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.

Ngày tải lên: 17/06/2020, 19:32

11 42 0
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients

The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients

... information To address this, we used a Random Forest classifier to determine how well our E2F4-based predictor performed in conjunction with clinical information and then compared the results to ... prognosis in breast cancer Breast Cancer Res 2014;16(6):486. 18 Bertucci F, Finetti P, Birnbaum D The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy. ... resolution to identify the highly proliferative patients most likely to respond to neoadjuvant chemo-therapy Going forward, it will be important to improve our methods to better predict pCR rate for

Ngày tải lên: 06/08/2020, 07:53

11 47 0
Preliminary study on the effects of treatment for breast cancer: Immunological markers as they relate to quality of life and neuropsychological performance

Preliminary study on the effects of treatment for breast cancer: Immunological markers as they relate to quality of life and neuropsychological performance

... radiation/chemotherapy treatment Out-comes for the active breast cancer treatment group were compared to breast cancer survivors (at least a year out of treatment) enlisted from a breast-cancer ... standard of care for breast cancer at that time Unfortunately, the molecular subtype of breast cancer (e.g., triple negative, HER2+, HR+) was not available for the active patient or breast cancer survivor ... beginning at diagnosis for early-stage breast cancer patients, and continuing through the course of treatment These interrelationships will be compared to those of a group of breast-cancer survivors

Ngày tải lên: 23/09/2020, 01:22

14 10 0
Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy

Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy

... Conclusions: Notch inhibitors may have potential in sensitizing breast cancer cells to chemotherapeutics and therefore in tackling chemoresistance Background Therapy for primary breast cancer usually involves ... published studies to suggest a potential cancer-specific regulatory pathway for MRP1 First, MRP1 was shown to be a direct transcriptional target of Notch1 in the multi-drug resistant breast cancer cell ... patients treated with neoadjuvant chemotherapy (NAC) for breast cancer, using immunohistochemistry on matched biopsy (pre-NAC) and surgical samples (post-NAC) Breast epithelial cell cultures (T47D,

Ngày tải lên: 28/09/2020, 01:37

12 8 0
Development and validation of a questionnaire to assess delay in treatment for breast cancer

Development and validation of a questionnaire to assess delay in treatment for breast cancer

... a cancer symptom were to present have been validated in asymptomatic patients [18,19], but no studies have assessed delay among breast cancer patients Some breast cancer delay studies refer to ... the breast cancer total, patient and provider intervals and the correlated factors with delays Due to the association between delay and prog-nosis for breast cancer [32], it is important to quantify ... recommended age for first screening mammogram 15 Cancer screening practices Last Pap smear Screening Breast Clinical Exam before current breast problem Mammograms before current breast problem Breast

Ngày tải lên: 05/11/2020, 08:13

13 15 0
Báo cáo hóa học: " A Novel Docetaxel-Loaded Poly (e-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment" pot

Báo cáo hóa học: " A Novel Docetaxel-Loaded Poly (e-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment" pot

... and therefore have considerable potential for treatment of breast cancer Keywords Nanoparticles  MDR  Pluronic F68  Poly (e-caprolactone) Docetaxel  Breast cancer Introduction Cancer remains ... commonly used in the treatment of breast cancer, oval cancer, small and nonsmall cell lung cancer, prostate cancer, etc Its commercial formulation TaxotereÒ is formulated in high concentration ... respect to various anticancer agents [13,14] The key attri-bute for the biological activity of Pluronics is their ability to incorporate into membranes followed by subsequent trans-location into the

Ngày tải lên: 22/06/2014, 00:20

10 363 0
báo cáo khoa học: "Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer" pdf

báo cáo khoa học: "Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer" pdf

... and postoperative) chemotherapy for locally advanced gastric cancer [3] Up to this point, many neoadjuvant chemotherapy treatments for gastric cancer have been used with varying success to downstage ... patients receiving FOLFOX7 neoadjuvant chemotherapy prior to radical gastrectomy for local advanced gastric cancer in comparison to patients who underwent gastrectomy alone during the same time period, ... gastrectomy for gastric cancer are pulmonary problems, anastomotic leakage, intra-abdominal abscess, and wound infection[9-12] Factors reported to influence morbidity in patients undergoing gastrectomy

Ngày tải lên: 09/08/2014, 02:21

27 243 0
báo cáo khoa học: "Novel therapies in breast cancer: what is new from ASCO 2008" ppsx

báo cáo khoa học: "Novel therapies in breast cancer: what is new from ASCO 2008" ppsx

... of breast cancer, two advances in targeted therapy have led to great strides in the understanding and treatment of breast cancer, namely hormonal therapy for estrogen positive receptor breast cancer ... using axitinib in breast cancer are ongoing Topoisomerase II inhibitors C1311 C1311 is an inhibitor of topoisomerase II whose design was based upon mitoxantrone but with less cardiotoxicity At 2008 ... directed therapies Treatment options for patients with breast cancer were tra-ditionally based on cytotoxic chemotherapy but now include therapies directed towards identifiable targets which sustain

Ngày tải lên: 10/08/2014, 22:20

13 415 0
báo cáo khoa học: "Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy" docx

báo cáo khoa học: "Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy" docx

... magnetoliposomes (Lip-Magh-Rh 2 (H 2 cit) 4 )induceda higher cytotoxicity on MCF-7 and 4T1 than on MCF-10A (p < 0.05). These treatments enhanced cytotoxicity up to 4.6 times. These cytotoxic ... cit) 4 ) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, its lower toxicity when compared to carboxylate analogues of rhodium ... 4 has significant antitumor, cytotoxic, and cyto- static activity on Ehrlich ascites tumor [7]. Although toxic to normal cells, its lower toxicity w hen compared to carboxylate analogues of rhodium

Ngày tải lên: 11/08/2014, 00:23

17 276 0
Liposomal co encapsulation of quercetin with synergistic chemotherapeutic drugs for breast cancer treatment

Liposomal co encapsulation of quercetin with synergistic chemotherapeutic drugs for breast cancer treatment

... regimens for breast cancer remain unsatisfactory The relapse rate for breast cancer patients is 85% (Bernard-Marty, Cardoso et al 2004) This highlights the Trang 24need for the continued research to ... express these receptors (Dizdar and Altundag 2010; Keshtgar, Davidson et al 2010) Chemotherapy is the cornerstone therapy for advanced breast cancer, especially for breast cancers that do not ... used were found to be hepatotoxic and nephrotoxic following intravenous administration Similarly, other microemulsions developed to solubilize quercetin were mainly preparations for topical (Kitagawa,

Ngày tải lên: 11/09/2015, 10:07

208 483 0
Early outcomes of surgical treatment with perioperative chemotherapy for gastric cancer

Early outcomes of surgical treatment with perioperative chemotherapy for gastric cancer

... partial distal gastrectomy due to cancer at the antrum and pylorus [19], the indication for total gastrectomy was considered preferable to proximal gastrectomy due to similar 5-year survival rate ... DISCUSSION Neo-adjuvant chemotherapy is indicated as a "down-staging" approach to advanced gastric cancer that aims to increase the ability to perform radical surgery For high-risk cases ... gastrectomy, lymphadenectomy of the standard D2 to D4 and removal of invaded organs into the block such as splenopancreatectomy, removal of peritoneal capsule of pancreas, left liver lobectomy

Ngày tải lên: 09/01/2020, 14:50

10 27 0
Combination versus single-agent as palliative chemotherapy for gastric cancer

Combination versus single-agent as palliative chemotherapy for gastric cancer

... survival information Pathologic information on the primary tumor of the stomach in both primary metastatic and recurrent disease was used for histologic subclassification, while histology was ... first-line chemotherapy Characteristics Before propensity score matching Total N (%) P value Single-agent Combination Gender After propensity score matching Total N (%) Chemotherapy Chemotherapy ... peritoneal metastases The most likely explanation for these findings is that oncologists judged that CC was too toxic for elderly patients and those with poor PS, whereas patients with peritoneal

Ngày tải lên: 17/06/2020, 03:27

10 18 0
Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase

Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase

... candidates for anticancer drugs [21] Tetran-drine and fangchinoline belong to bisbenzylisoquinoline alkaloids In this paper, potential antiproliferative small molecules for breast cancer were ... inhibiting MDA-MB-435 breast cancer cells expansion MTT method We seeded MDA-MB-435 breast cancer cells into 96-well plate at the density of 8 × 103each well and cultured for 12 h when they were ... colony forming assay found that HJNO also had a strong inhibitory effect on the colony formation of MDA-MB-435 breast cancer cells The mRNA and protein expression of BLM helicase in MDA-MB-435 breast

Ngày tải lên: 17/06/2020, 18:15

12 7 0
Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: A systematic review

Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: A systematic review

... Background: Breast cancer related lymphedema (BCRL) is a prevalent complication secondary to cancer treatments which significantly impacts the physical and psychological health of breast cancer survivors ... mitochondrial respiratory chain such as cytochromes, cytochrome oxidase, and flavin dehydrogenases; these result in changes in reduction–oxidation reaction (REDOX) status of cytoplasm and mitochondria, ... have yet to be elucidated Keywords: Low level laser therapy, Photobiomodulation, Breast cancer related lymphedema, Systematic review * Correspondence: david.baxter@otago.ac.nz Centre for Health,

Ngày tải lên: 06/08/2020, 03:41

13 24 0
Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes

Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes

... were increased in breast cancer (Fig 1b, p < 0.01) Compared to the normal breast cancer cell line MCF-10A, miR-1908-3p levels were also found to be enhanced in two breast cancer cell lines ... of tumor, including breast cancer Therefore, miR-1908-3p may target these eight genes to faciliate the progress of breast cancer and decrease the survival time of breast cancer patients Fig 7 ... miR-1908-3p in the breast cancer tissues miR-1908-3p expression p value Abbreviations: ER estrogen receptor, PR progesterone receptor, HER-2 human epidermal growth factor receptor 2 Trang 4Bioinformatics

Ngày tải lên: 06/08/2020, 05:32

12 9 0
Weight change during chemotherapy in breast cancer patients: A meta-analysis

Weight change during chemotherapy in breast cancer patients: A meta-analysis

... weight”, “breast cancer”, “breast neoplasm”, “breast carcinoma”, “breast tumor”, “breast tumour”, “breast adenoma”, “mamma,” “chemotherapy”, “chemo” and “cytostatic” (see Additional file for more ... Therefore, the purpose of this metaanalysis was to quantify changes in body weight during chemotherapy for women with early stage breast cancer, and to assess which factors contributed to the ... significant weight gain during chemotherapy for women with early stage breast cancer Treatment for breast cancer has changed over time Before the 1990s, only CMF was used as chemotherapy regime, while

Ngày tải lên: 19/09/2020, 21:45

13 15 0
w